Columbia’s Center for Liver Disease and Transplantation at NewYork-Presbyterian was one of the first liver programs in the United States to create a multidisciplinary unit from the outset. Our team includes hepatologists, gastroenterologists, hepatobiliary surgeons, diagnostic and pathology experts, advanced-care nurses, social workers, and patient support staff affiliated with the program.
We have cared for thousands of children and adults with liver disease and liver cancer since the center formed in 1998. Our experts have broad experience in diagnosing and treating all forms and stages of liver disease, such as antiviral treatment for Hepatitis C and Hepatitis B and liver transplantation. We assess and treat liver disease with standard medical therapy, investigational protocols, and surgical therapy.
Furthermore, we offer novel treatments for patients with liver cancer and cancers of the bile duct, or cancer that started elsewhere in the body and has spread to the liver. Columbia’s Center for Liver Disease and Transplantation participates in multiple government- and industry-funded clinical research studies. Our patients have the opportunity to receive treatments available in only a few centers, or in no other centers. We are also a major center for the study of treatment outcomes for liver disease treatment and liver transplantation.
For more information, visit: